Clinical Trial Update: SBRT Plus Systemic Therapy vs Systemic Therapy Alone in BCLC C Hepatocellular Carcinoma [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial evaluates adding SBRT to systemic therapy versus systemic therapy alone for hepatocellular carcinoma with BCLC stage C. The study is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Shandong Cancer Hospital and Institute | Conditions: Hepatocellular Carcinoma, BCLC Stage C Hepatocellular Carcinoma | Phase 2 | Status: RECRUITING